Early Non-Response in Patients with Severe Depression
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference32 articles.
1. The burden of severe depression: A review of diagnostic challenges and treatment alternatives
2. Treatment of Men With Major Depression
3. Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation;European Journal of Pharmacology;2024-03
2. The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review;Expert Opinion on Pharmacotherapy;2021-02-22
3. Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder;Journal of Clinical Psychopharmacology;2020-11-18
4. Changes in antidepressant therapy should be considered early in patients with inadequate response to a first-line agent;Australian & New Zealand Journal of Psychiatry;2020-10-28
5. Pharmacological interventions for treatment-resistant depression in adults;Cochrane Database of Systematic Reviews;2019-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3